Literature DB >> 12720209

Late effects of childhood cancer therapy.

Sarah J Bottomley1, Elizabeth Kassner.   

Abstract

One in every 900 young adults is a survivor of childhood cancer. Survivors may experience a wide variety of late effects stemming from the treatment they received. It is estimated that a significant portion of adult survivors of childhood cancer are not followed regularly in a center familiar with the late effects of their specific therapy. Therefore it is important for health care professionals in any setting to have an understanding of these possible late effects and encourage the survivor to seek appropriate follow-up. This article will provide a general overview of the potential late effects of childhood cancer therapy. Copyright 2003, Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2003        PMID: 12720209     DOI: 10.1053/jpdn.2003.13

Source DB:  PubMed          Journal:  J Pediatr Nurs        ISSN: 0882-5963            Impact factor:   2.145


  3 in total

1.  Modernizing Clinical Trial Eligibility: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Minimum Age Working Group.

Authors:  Lia Gore; S Percy Ivy; Frank M Balis; Eric Rubin; Katherine Thornton; Martha Donoghue; Samantha Roberts; Suanna Bruinooge; Jennifer Ersek; Nancy Goodman; Caroline Schenkel; Gregory Reaman
Journal:  J Clin Oncol       Date:  2017-10-02       Impact factor: 44.544

2.  Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observational Cohort Study.

Authors:  Kelly R McMahon; Shahrad Rod Rassekh; Kirk R Schultz; Maury Pinsk; Tom Blydt-Hansen; Cherry Mammen; Ross T Tsuyuki; Prasad Devarajan; Geoff D E Cuvelier; Lesley G Mitchell; Sylvain Baruchel; Ana Palijan; Bruce C Carleton; Colin J D Ross; Michael Zappitelli
Journal:  Can J Kidney Health Dis       Date:  2017-02-16

3.  Safety of Complementary and Alternative Medicine (CAM) treatment among children and young adults who suffer from adverse effects of conventional cancer treatment: A systematic review.

Authors:  Dana C Mora; Agnete E Kristoffersen; Grete Overvåg; Miek C Jong; Marit Mentink; Jianping Liu; Trine Stub
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.077

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.